journal article·2021-09

Powder X-ray diffraction of pazopanib hydrochloride Form 1, C 21 H 24 N 7 O 2 SCl

James A. Kaduk, Amy M. Gindhart, Thomas N. Blanton

Powder Diffraction· Volume 36· Issue 3
Publisher page

Abstract

The crystal structure of pazopanib hydrochloride Form 1 has been refined using synchrotron X-ray powder diffraction data and optimized using density functional theory techniques. Pazopanib hydrochloride crystallizes in space group P -1 (#2) with a = 8.45008(6), b = 8.71310(12), c = 16.05489(35) Å, α = 79.5996(9), β = 86.4784(5), γ = 87.3764(3)°, V = 1159.724(9) Å 3 , and Z = 2. The crystal structure is essentially identical to that of CSD Refcode CEVYEK. There are four strong N–H⋯Cl hydrogen bonds to the chloride anion. Several additional weaker N–H⋯Cl and C–H⋯Cl hydrogen bonds are also present. A variety of C–H⋯O, C–H⋯N, and N–H⋯S hydrogen bonds also contribute to the lattice energy. The powder pattern has been submitted to ICDD ® for inclusion in the Powder Diffraction File™.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: X-ray Diffraction in Crystallography · Crystallography and molecular interactions · Thermal and Kinetic Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (11)

Show source-provided references
1. 10.1017/S088571561900081210.1017/S0885715619000812 ↗
2. Chava, S. , Gorantla, S. R. A. , Indukuri, V. S. K. , Dehury, S. K. , Mekala, N. , Shaik, J. B. , and Kuchipudi, D. P. (2016). “An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof,” US Patent Application 2016/0280689 A1.
3. 10.1107/S002188981101462210.1107/S0021889811014622 ↗
4. Rybakov, V. B. , Putilova, E. V. , and Nhernobrovkin, M. G. (2018). “Pazopanib hydrochloride,” CSD Communication (Private Communication).
5. 10.1002/qua.2465810.1002/qua.24658 ↗
6. 10.1021/ci049780b10.1021/ci049780b ↗
7. 10.1107/S205252061600395410.1107/S2052520616003954 ↗
8. 10.1063/1.46788210.1063/1.467882 ↗
9. Chava, S. , Gorantla, S. R. A. , Indukuri, V. S. K. , Dehury, S. K. , Mekala, N. , Shaik, J. B. , and Kuchipudi, D. P. (2015). “An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof,” International Patent Application WO 2015/068175 A2.
10. 10.1107/S002188981300353110.1107/S0021889813003531 ↗
11. 10.1002/jcc.2315310.1002/jcc.23153 ↗